학술논문
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
Document Type
Article
Author
Source
In Annals of Oncology December 2014 25(12):2357-2362
Subject
Language
ISSN
0923-7534